HUS year 2024: Productivity, service production and funding

Productivity

In 2024, we monitored the development of total productivity with a cost-per-patient indicator, targeting a 1% decrease. Price changes were accounted for in the comparison.

Cost per patient decreased by 3.7% on the previous year to EUR 3,531 on average.

Service production

The comparable operating volume of medical services was 2.8% over budget while showing an increase of 2.4% on the previous year. 

Funding

In 2024, we withdrew EUR 165 million in new long-term loans, as budgeted, and paid EUR 34.8 million in loan amortizations. As at the end of 2024, our loan portfolio stood at EUR 1,126.4 million. The loan portfolio consisted of long-term loans. Our loan receivables totaled EUR 22.9 million.  

HUS’s cash and cash equivalents at the end of 2024 amounted to EUR 111.5 million.  

Cash flow sufficiency was 12.6 days, meaning that the minimum objective of 12 days was attained in 2024.  

HUS had an equity ratio of 12.9%, the target minimum being 15%.